![Rajiv Patni](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rajiv Patni
Chief Tech/Sci/R&D Officer at
SEPTERNA, INC.
Net worth: - $ as of 31/07/2026
Profile
Rajiv Patni is Director at BioXcel Therapeutics, Inc. since 2025 and Chief Medical Officer at Septerna, Inc. since 2026.
Former roles include Chief Executive Officer & Director at Judo Bio, Inc., Executive Director & Vice President at Roche Pharmaceuticals, Inc., Independent Director at Quince Therapeutics, Inc. from 2024 to 2026, Senior Medical Director at Novartis Pharmaceuticals Corp., Senior Medical Director at Pfizer Pharmaceuticals, Inc., Executive VP, Chief Research & Development Officer at Reata Pharmaceuticals, Inc. in 2023, Chief Medical Officer at Adamas Pharmaceuticals LLC from 2015 to 2020, Chief Development Officer at OCERA Therapeutics LLC from 2014 to 2015, Chief Medical Officer at Actelion Pharmaceuticals US, Inc. from 2007 to 2014, Chief Medical Officer & Executive Vice President at Portola Pharmaceuticals LLC in 2020, and Chief Medical Officer at Global Blood Therapeutics, Inc. from 2020 to 2023.
Education includes a doctorate from Icahn School of Medicine at Mount Sinai and an undergraduate degree from The Sophie Davis School of Biomedical Education.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/01/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Rajiv Patni active positions
| Companies | Position | Start |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Director/Board Member | 15/01/2025 |
| SEPTERNA, INC. | Chief Tech/Sci/R&D Officer | 25/08/2026 |
Former positions of Rajiv Patni
| Companies | Position | End |
|---|---|---|
| QUINCE THERAPEUTICS, INC. | Director/Board Member | 30/01/2026 |
| REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 26/09/2023 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2023 |
| PORTOLA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/07/2020 |
| ADAMAS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 15/02/2020 |
Training of Rajiv Patni
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Pharmaceuticals, Inc.
 Pfizer Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
The Sophie Davis School of Biomedical Education
 The Sophie Davis School of Biomedical Education Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Septerna, Inc.
 Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism | Health Technology |
Judo Bio, Inc.
 Judo Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops oligonucleotide medicine | Health Technology |
- Stock Market
- Insiders
- Rajiv Patni
